Update on vaccine-derived polioviruses — worldwide, January 2016–June 2017

Morbidity and Mortality Weekly Report

Volumn 66, Issue 43, 2017, Pages 1185-1191

  Jorba, Jaume ^a   Diop, Ousmane M ^b   Iber, Jane ^a   Henderson, Elizabeth ^a   Sutter, Roland W ^b   Wassilak, Steven G F ^c   Burns, Cara C ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; ORAL POLIOMYELITIS VACCINE; SEWAGE;

CHILD; CLASSIFICATION; EPIDEMIC; FEMALE; GENETICS; GLOBAL HEALTH; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; ISOLATION AND PURIFICATION; MALE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; SEROTYPING; SEWAGE; STATISTICS AND NUMERICAL DATA; VIROLOGY;

CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; GLOBAL HEALTH; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEROTYPING; SEWAGE; VACCINES, ATTENUATED;

EID: 85032892363     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6643a6     Document Type: Article

References (10)

1. Morales M, Tangermann RH, Wassilak SG. Progress toward polio eradication—worldwide, 2015–2016. MMWR Morb Mortal Wkly Rep 2016;65:470–3. https://doi.org/10.15585/mmwr.mm6518a4
2. Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis 2014;210(Suppl 1):S283–93. https://doi.org/10.1093/infdis/jiu295
3. Jorba J, Diop OM, Iber J, Sutter RW, Wassilak SG, Burns CC. Update on vaccine-derived polioviruses—worldwide, January 2015–May 2016. MMWR Morb Mortal Wkly Rep 2016;65:763–9. https://doi.org/10.15585/mmwr.mm6530a3
4. Hampton LM, Farrell M, Ramirez-Gonzalez A, et al.; Immunization Systems Management Group of the Global Polio Eradication Initiative. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine—worldwide, 2016. MMWR Morb Mortal Wkly Rep 2016;65:934–8. https://doi.org/10.15585/mmwr.mm6535a3
5. Diop OM, Asghar H, Gavrilin E, et al. Virologic monitoring of poliovirus type 2 after oral poliovirus vaccine type 2 withdrawal in April 2016— worldwide, 2016–2017. MMWR Morb Mortal Wkly Rep 2017;66:538–42. https://doi.org/10.15585/mmwr.mm6620a4
6. Burns CC, Kilpatrick DR, Iber JC, Chen Q, Kew OM. Molecular properties of poliovirus isolates: nucleotide sequence analysis, typing by PCR and real-time RT-PCR. Methods Mol Biol 2016;1387:177–212. https://doi.org/10.1007/978-1-4939-3292-4_9
7. Etsano A, Damisa E, Shuaib F, et al. Environmental isolation of circulating vaccine-derived poliovirus after interruption of wild poliovirus transmission—Nigeria, 2016. MMWR Morb Mortal Wkly Rep 2016;65:770–3. https://doi.org/10.15585/mmwr.mm6530a4
8. Cowger TL, Burns CC, Sharif S, et al. The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan—2011–2013. PLoS One 2017;12:e0180608. https://doi.org/10.1371/journal.pone.0180608
9. Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SG. Surveillance systems to track progress toward polio eradication— worldwide, 2015–2016. MMWR Morb Mortal Wkly Rep 2017;66:359–65. https://doi.org/10.15585/mmwr.mm6613a3
10. Aghamohammadi A, Abolhassani H, Kutukculer N, et al.; JMF Centers Network Investigators and Study Collaborators. Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication. Front Immunol 2017;8:685. https://doi.org/10.3389/fimmu.2017.00685